L. Schenkel

1.2k total citations
16 papers, 968 citations indexed

About

L. Schenkel is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Dermatology. According to data from OpenAlex, L. Schenkel has authored 16 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 6 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Dermatology. Recurrent topics in L. Schenkel's work include Estrogen and related hormone effects (9 papers), Dermatology and Skin Diseases (4 papers) and Menopause: Health Impacts and Treatments (4 papers). L. Schenkel is often cited by papers focused on Estrogen and related hormone effects (9 papers), Dermatology and Skin Diseases (4 papers) and Menopause: Health Impacts and Treatments (4 papers). L. Schenkel collaborates with scholars based in Switzerland and United Kingdom. L. Schenkel's co-authors include William R. Good, Virgil A. Place, Urs R. Joss, Marc de Gasparo, Steven Whitebread, Michel Biollaz, Julius Schmidlin, Patricia Campbell, Malcolm Whitehead and A.S. Bhatnagar and has published in prestigious journals such as The Lancet, FEBS Letters and Journal of Controlled Release.

In The Last Decade

L. Schenkel

15 papers receiving 873 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Schenkel Switzerland	12	585	348	145	135	125	16	968
Rémi Delansorne United States	15	218 0.4×	313 0.9×	368 2.5×	43 0.3×	6 0.0×	31	1.0k
Dianne Deplewski United States	12	132 0.2×	76 0.2×	457 3.2×	515 3.8×	46 0.4×	23	1.2k
E.H.D. Cameron United Kingdom	17	478 0.8×	281 0.8×	176 1.2×	11 0.1×	6 0.0×	43	918
A. Lemay Canada	19	346 0.6×	161 0.5×	217 1.5×	8 0.1×	6 0.0×	48	1.2k
Thomas P. Conlon United States	15	247 0.4×	116 0.3×	588 4.1×	3 0.0×	30 0.2×	18	1.3k
Hirofumi Imoto Japan	15	110 0.2×	61 0.2×	148 1.0×	11 0.1×	32 0.3×	43	554
Faris Azzouni United States	9	213 0.4×	85 0.2×	170 1.2×	34 0.3×	4 0.0×	15	629
Jacobie Steenbergen Netherlands	19	267 0.5×	98 0.3×	246 1.7×	4 0.0×	7 0.1×	31	927
Takara Yamamoto Japan	16	152 0.3×	309 0.9×	147 1.0×	4 0.0×	3 0.0×	40	839
Fernand Labrie Canada	19	733 1.3×	515 1.5×	368 2.5×	24 0.2×	2 0.0×	35	1.2k

Countries citing papers authored by L. Schenkel

Since Specialization

Citations

This map shows the geographic impact of L. Schenkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Schenkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Schenkel more than expected).

Fields of papers citing papers by L. Schenkel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Schenkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Schenkel. The network helps show where L. Schenkel may publish in the future.

Co-authorship network of co-authors of L. Schenkel

This figure shows the co-authorship network connecting the top 25 collaborators of L. Schenkel. A scholar is included among the top collaborators of L. Schenkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Schenkel. L. Schenkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Whitehead, Malcolm, et al.. (1993). Does low-dose, transdermal, norethisterone acetate reliably cause endometrial transformation in postmenopausal oestrogen-users?. Maturitas. 16(1). 23–30. 10 indexed citations

Bhatnagar, A.S., et al.. (1992). Inhibition of estrogen biosynthesis and its consequences on gonadotrophin secretion in the male. The Journal of Steroid Biochemistry and Molecular Biology. 41(3-8). 437–443. 48 indexed citations

Illig, R, Mariarosaria Lang‐Muritano, A. Prader, et al.. (1990). A physiological mode of puberty induction in hypogonadal girls by low dose transdermal 17β-oestradiol. European Journal of Pediatrics. 150(2). 86–91. 32 indexed citations

Whitehead, Malcolm, et al.. (1990). Transdermal administration of oestrogen/progestagen hormone replacement therapy. The Lancet. 335(8685). 310–312. 63 indexed citations

Häusler, A., et al.. (1989). An In vitro method to determine the selective inhibition of estrogen biosynthesis by aromatase inhibitors. Journal of Steroid Biochemistry. 33(1). 125–131. 23 indexed citations

Schenkel, L., et al.. (1988). [Estrogen substitution using a transdermal system].. PubMed. 83(6). 453–8. 2 indexed citations

Gasparo, Marc de, Urs R. Joss, Steven Whitebread, et al.. (1987). Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro.. Journal of Pharmacology and Experimental Therapeutics. 240(2). 650–656. 264 indexed citations

Schenkel, L., et al.. (1987). [Transdermal estradiol substitution in the postmenopause, individual dosage adjustment and effectiveness in the treatment of climacteric symptoms].. PubMed. 76(14). 358–61. 1 indexed citations

Ip, Margot M., Paul W. Sylvester, & L. Schenkel. (1986). Antitumor efficacy in rats of CGP 19984, a thiazolidinedione derivative that inhibits luteinizing hormone secretion.. PubMed. 46(4 Pt 1). 1735–40. 16 indexed citations

10.

Schenkel, L., et al.. (1986). Transdermal absorption of estradiol 101 from different body sites is comparable. Journal of Controlled Release. 4(3). 195–201. 13 indexed citations

11.

Schenkel, L., et al.. (1985). Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol: Comparison with conventional oral estrogens used for hormone replacement. American Journal of Obstetrics and Gynecology. 152(8). 1099–1106. 245 indexed citations

12.

Good, William R., et al.. (1985). A new transdermal delivery system for estradiol. Journal of Controlled Release. 2. 89–97. 93 indexed citations

13.

Place, Virgil A., et al.. (1985). A double-blind comparative study of Estraderm and Premarin in the amelioration of postmenopausal symptoms. American Journal of Obstetrics and Gynecology. 152(8). 1092–1099. 73 indexed citations

14.

Schenkel, L., et al.. (1984). 17β-Estradiol For Postmenopausal Estrogen Replacement Therapy. Obstetrical & Gynecological Survey. 39(4). 230–230. 64 indexed citations

15.

Märki, F., L. Schenkel, Andrew J. Czernik, et al.. (1981). Rapid conversion of somatostatin to active metabolite in human plasma. FEBS Letters. 127(1). 22–24. 10 indexed citations

16.

McMartin, Colin, L. Schenkel, R. Maier, et al.. (1977). DIFFERENCES BETWEEN IN-VITRO AND IN-VIVO POTENCIES OF CORTICOTROPHINS: AN INTERPRETATION IN TERMS OF METABOLIC STABILITY. Journal of Endocrinology. 73(1). 79–89. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact